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THE IMPACT OF PAROXYSMAL SYMPATHETIC HYPERACTIVITY 
FOLLOWING TRAUMATIC BRAIN INJURY ON INTENSIVE CARE UNIT 
LENGTH OF STAY AND DISCHARGE DISPOSITION	
Kimberly S Meyer	
October 25, 2016	
Paroxysmal Sympathetic Hyperactivity (PSH) is a complication 
affecting a subset of patients with severe traumatic brain injury (TBI). It is 
associated with increased morbidity, longer lengths of stay, and delayed 
recovery (Perkes, Baguley, Nott, & Menon, 2010). The most prevalent 
signs and symptoms of PSH include unprovoked tachycardia, tachypnea, 
hypertension, dystonia, and diaphoresis (Lemke, 2007). If untreated, PSH 
can lead to impaired cerebral blood flow, sub-endocardial damage, 
dehydration, malnourishment, and contractures (Lemke, 2007).  
The purpose of this study was to determine the incidence of PSH in 
an American Level 1 trauma center, examine the differences between 
patients with severe TBI and those who develop PSH in terms of intensive 
care unit length of stay (ICULOS) and discharge disposition, and identify 
predictors of ICULOS in the patients with PSH. Data were abstracted from 
medical records (N=196) of patients with TBI.	
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Results from this retrospective study indicate that there was no 
difference in intensive unit (ICU) length of stay in TBI patients with PSH 
compared to those without PSH. However, there was a significant 
difference in discharge disposition, so that patients without PSH were 
more likely to be discharged to a home or acute rehabilitation setting while 
those with PSH were more likely to be discharged to sub-acute 
rehabilitation or other high level medical care. Evaluation of physiologic 
parameters known to be abnormal in patients with PSH indicated that in 
this sample, only heart rate was a significant predictor of the development 
of PSH. This suggests that is it reasonable to screen younger patients 
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      CHAPTER I	
INTRODUCTION		
Traumatic brain injury (TBI) affects over 1 million Americans annually 
(Centers for Disease Control and Prevention (CDC), 2010). Although only a small 
percentage of TBI is categorized as severe, this subgroup is at risk for prolonged 
hospital stays, persistent disability, and increased lifetime healthcare utilization 
resulting in significant burden to the healthcare system (CDC, 2010; Perkes et 
al., 2010; Whitmore et al., 2012). Acute care length of stay following 
uncomplicated severe TBI averages 18 days with hospital charges upward of 
$95,000 per stay (Frankel et al., 2006). Up to one third of all severe TBI survivors 
may develop paroxysmal sympathetic hyperactivity (PSH), a condition that 
further complicates TBI recovery and lessens the likelihood for functional 
recovery (Hinson & Sheth, 2012; Whyte et al., 2013). International literature 
suggests that those patients with PSH are at risk for prolonged lengths of stay in 
the intensive care unit and increased morbidity (Fernandez-Ortega et al., 2012).	
Clinical experience suggests that delayed mobilization, longer intensive 
care unit length of stay (ICULOS), delayed coma emergence, and failure to 
qualify for acute brain injury rehabilitation are related to autonomic instability
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(Figure 1). Identification of predictors most influential in ICULOS may lead to 
earlier intervention and control of autonomic discharges. In turn, this might
facilitate the earlier use of pharmacologic neuro-stimulation, rehabilitation and 
expedite discharge to high level brain injury recovery programs (Wheaton, 
Mathias, & Vink, 2009; Whyte et al., 2013) as specialized care by neurotrauma 
specialists in acute care and rehabilitation is known to improve hospital outcome 
and the likelihood of community re-integration following TBI (Haas et al., 2009; 
Kramer & Zygun, 2014; Whyte et al., 2013).	
The purpose of this dissertation was threefold. First, the study aimed to 
determine the incidence of PSH in an American sample of severe TBI patients 
treated at a level 1 trauma center. Secondly, it sought to examine the effect of 
PSH on short-term outcome as measured by discharge destination. Lastly, the 
study explored the predictors that most influence ICULOS in patients with PSH. 	
The first manuscript is a review of literature. It indicates that PSH is a 
poorly understood condition and as a result, recognition and treatment of the 
symptom complexes is often delayed (Fernandez-Ortega et al., 2006). Brief, but 
frequent episodes of hemodynamic instability and physiologic distress 
manifested by shaking and profuse diaphoresis are the hallmarks of this 
condition (Lemke, 2007). Imaging studies in patients experiencing PSH often 
reveal evidence of diffuse axonal injury (Baguley, 2004; Baguley, 1999; Boeve, 
Wijdicks, Benarroch, & Schmidt 1998a; Bower, 2010). Coma emergence and 
weaning from high dose opiates and sedatives are precursors frequently 
associated with the onset of signs and symptoms associated with PSH. 	
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The second manuscript provides a concept analysis, comparing the 
sympathetic hyperactivity of PSH to the sympathetic surges seen in contrary 
cases of cerebral herniation syndrome. It identifies surrogate terms for PSH that 
were frequently used prior to the development of a standardized definition and 
nomenclature. Nursing surveillance was identified as a critical factor in the 
identification of PSH related symptoms.	
The final manuscript presents findings from a retrospective study of 196 
patients who had sustained a severe traumatic brain injury. The subjects were 
dichotomized into groups: those with PSH and those with normal TBI recovery 
trajectory. Although there was no difference in ICULOS between the two groups, 
those with PSH were less likely to discharge to acute rehabilitation than their 
counterparts without PSH. Heart rates at multiple time points were most 
predictive of the condition of PSH.	
Results from this dissertation suggest that patients with coma after TBI 
who develop unprovoked periods of tachycardia should be further screened for 
PSH. Other findings indicate that those with higher discharge Glasgow Coma 
Scores, as seen in the TBI group, were associated with discharge to high-level 
brain injury rehabilitation.  
Figure 1 
Theoretical Effect of PSH on TBI Recovery 
 
The expected recovery course of traumatic brain injury (TBI) follows the path from acute care to rehabilitation and 
community re-entry. The effects of paroxysmal sympathetic hyperactivity (PSH) may alter the recovery trajectory and 
delay or prohibit maximal recovery



















UNDERSTANDING PAROXYSMAL SYMPATHETIC HYPERACTIVITY 
AFTER TRAUMATIC BRAIN INJURY (Meyer, 2014: Appendix 1)		
Overview	
Traumatic brain injury (TBI) affects 1.4 million Americans annually (CDC, 
2010). Although only a small percentage of TBI is categorized as severe or 
comatose state, this subgroup of patients is at risk for prolonged hospital stays, 
persistent disability, and increased lifetime healthcare utilization (CDC, 2010). 
This sub-population of patients with TBI accounts for up to ninety percent of all 
TBI-related costs (CDC, 2010).  Paroxysmal sympathetic hyperactivity (PSH) has 
been reported in up to 33% of patients with severe TBI (Hinson & Sheth, 2012).	
PSH has been discussed in the literature under a variety of terms. Early in 
the recognition of this phenomenon, the term diencephalic seizure was used 
(Penfield, 1929). However, later investigations failed to demonstrate epileptiform 
discharges on electroenecephalography so this term has seen a decrease in 
usage (Boeve et al., 1998a; Lemke, 2007). PSH later became known as 
dysautonomia, autonomic storming, sympathetic storming, and autonomic
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dysreflexia or hyper-reflexia (Baguley et al., 1999). The International Brain Injury 
Association has recently convened a consensus workgroup to clarify the 
nomenclature and diagnostic criteria for this entity. The proposed term from this 
consensus group is paroxysmal sympathetic hyperactivity (Baguley et al., 2014). 
To date, the vast majority of literature pertaining to PSH is found in the medical 
literature with attention paid to hypothesis of cause and pharmacologic 
management. With few exceptions, studies are limited to retrospective reviews, 
case studies, or small case series, thereby limiting their generalizability. 	
PSH is a poorly understood phenomenon with varied symptomatology. As 
a result, identification of the condition is often delayed (Hendricks, Heeren, & 
Vos, 2010). Diagnosis is often one of exclusion, where other conditions with 
similar symptoms, such as infection or withdrawal, are ruled out. Brief, but 
frequent episodes of hemodynamic instability and physiologic distress are the 
hallmarks of this condition (Baguley et al., 2014; Lemke, 2007). Imaging studies 
in patients experiencing sympathetic storming often reveal evidence of diffuse 
axonal injury (Baguley et al., 2004; Boeve et al., 1998a). Coma emergence and 
weaning from high dose opiates and sedatives are precursors that are frequently 
associated with sign or symptom exhibition. Baguley et al., suggest that PSH is 
present if the following symptoms occur without other identifiable causes: 
hyperthermia, tachycardia, tachypnea, dystonia, hypertension, posturing and 
diaphoresis (Baguley et al., 1999; Lemke, 2007). Identification of these signs or 




PSH is thought to occur in stages. The first stage is often asymptomatic 
due to the heavy sedation and paralytics required for the acute management of 
intracranial hypertension and other trauma-related injuries. The second stage is 
characterized by the onset of symptom clusters and the third stage, by a decline 
in posturing and dystonia (Baguley et al, 1999). Baguley, Nott et al., (2009) and 
Baguley, Heriseanu et al., (2009) demonstrated that changes in heart rate 
variability associated with nociceptive stimuli accompany the onset of 
sympathetic storming. Retrospective reviews indicate that those with diffuse 
axonal injury on imaging studies are at highest risk for developing sympathetic 
storming (Baguley et al., 1999; Hendricks et al., 2010). Symptoms are thought to 
persist for months to years, with one study revealing a mean duration of 5 years 
post-injury (Baguley et al., 2009).	
Various dissociation theories provide the theoretical framework for PSH. 
These include those of structural disconnection where lesions in the 
mesencephalon cause disruptions in relay from the medulla/hypothalamus and 
the more widely accepted excitatory: inhibitory ratio (EIR) model where 
dysfunction of the diencephalic-brainstem inhibitory center that normally controls 
afferent stimulus processing in the spinal cord occurs (Baguley, 2008b; 
Fernandez-Ortega et al., 2006; Lemke, 2007). Autonomic dysfunction is thought 
to result from functional disconnections related to traumatic damage involving the 
deep structures of the brain (Baguley, Heriseanu, Cameron et al., 2008). This is 
complicated by a relative reduction in functional dopaminergic activity (Baguley, 
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Heriseanu, Cameron et al., 2008). As a result, there is unopposed adrenergic 
outflow with increased levels of circulating catecholamines (Baguley, Heriseanu, 
Cameron et al., 2008). Within this framework, there is an increase in the 
excitatory influences without a compensatory increase in inhibitory function, thus 
creating a tendency to develop an over-reaction to normally non-noxious stimuli 
(Baguley, Heriseanu, Nott et al., 2009; Baguley, Nott, Slewa-Younan et al., 
2009). Multisystem organ dysfunction can follow if the condition is untreated.	
Treatment	
There is no accepted treatment algorithm for the management of PSH. 
Treatment is aimed at mitigating signs and symptoms to decrease associated 
adverse events such as cardiac hypertrophy, dehydration, muscle wasting, 
contractures, and delayed recovery which contribute to increased morbidity 
(Table 1). Multiple medications are often required to successfully control the 
multiple symptoms. Dopaminergic agents, specifically bromocriptine, have been 
shown to decrease body temperature and sweating (Bullard, 1987; Rossitch & 
Bullard, 1988; Russo & O’Flaherty, 2000). Alpha-agonists such as clonidine act 
to decrease heart rate and blood pressure (Payen, Quentin, Plaisance, Chiron, & 
Lhoste, 1990; Russo & O’Flaherty, 2000; Patel et al., 2012). GABA agonists are 
also useful in some cases. Baclofen can be given enterally or intrathecally. 
Intrathecal baclofen significantly reduces symptoms at substantially lower doses 
and subsequently, less toxicity (Cuny, Richer, & Castel, 2001; Becker, Benes, 
Sure, Hellwig, & Bertanlanffy, 2000). Gabapentin is thought to act on the dorsal 
horn of the spinal cord and in one small study, reduced the need for concomitant 
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medications (Baguley, Slewa-Younan, et al., 2007). Opiates and non-selective 
beta-blockers have also been used (Baguley  et al., 2004; Bullard, 1987).	
In cases of medication failure, a case series of six patients demonstrated 
that hyperbaric oxygen (HBOT) controlled autonomic discharges and posturing in 
the sub-acute TBI phase (Lv et al., 2011). However, this treatment modality is of 
limited utility as there are an inadequate number of facilities with HBOT 
capabilities and the duration of therapy is prohibitive. Large experimental studies 
to validate the findings in these smaller studies are challenging due to difficulties 
in early identification of PSH and the relatively small number of qualifying 
patients.	
Implications	
Early identification and treatment of PSH is critical to facilitate recovery 
from traumatic brain injury and avoid permanent organ dysfunction. Expensive 
diagnostic testing is rarely warranted. Instead, the observational and analytical 
skills employed by most ICU nurses are more useful in recognizing PSH. In 
addition to communication of findings in order to facilitate diagnosis and 
treatment, nursing surveillance also affords the opportunity to identify and 
therefore potentially mitigate triggers. A final contribution of nursing involves 
family and caregiver teaching. In this role, the nurse explains the concept of 
PSH, along with its causes and treatment, thereby aiding the family member to 
better cope with the paroxysms that can be very frightening or chaotic to watch. 	
Early initiation of symptom specific therapy, although beyond the scope of 
this paper, is thought to decrease complication rates and ICU length of stay and 
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to facilitate recovery (Hinson & Sheth, 2012). Understanding both the cause and 
complexity of these storming (PSH) events will lead to appropriate diagnosis and 
improved therapeutic interventions.	
Conclusion	
PSH should be considered when patients emerging from coma exhibit 
multiple, concurrent symptoms of sympathetic over-activity: hyperthermia, 
posturing, dystonia, tachycardia, tachypnea, diaphoresis, or hypertension. 
Nurses play a pivotal role in identifying the condition of PSH, observing and 
mitigating the triggers which precipitate the event, communicating patient needs 
to the interdisciplinary team and finally, educating the family/caregivers. Ongoing 
research should include efforts to develop scales to document the frequency and 
severity of these paroxysmal episodes and treatment algorithms to guide the 









● Increased cardiac output	
Pulmonary	 ● Tachypnea	
● Bronchial dilation		
Eyes	 ● Pupillary dilation	
Gastrointestinal	 ● Decreased GI motility	






Adrenal	 ● Increased release of epinephrine	







A CONCEPT ANALYSIS OF PAROXYSMAL SYMPATHETIC 
HYPERACTIVITY AFTER SEVERE TRAUMATIC BRAIN INJURY	
Overview 
Paroxysmal Sympathetic Hyperactivity (PSH) is a phenomenon that is 
seen following a variety of neurological insults. In particular, it is well described 
following severe traumatic brain injury (TBI) (Baguley, 2008a; Baguley et al., 
2006; Baguley, Nott et al., 2009; Boeve et al., 1998a; Lv et al., 2011). PSH 
consists of paroxysmal sympathetic discharges (Baguley, 2008b; Lemke, 2007) 
thought to result from an imbalance in afferent and efferent systems which alter 
the normal excitatory:inhibitory ratio (EIR) of the autonomic nervous system 
(Baguley, 2008b). This results in a constellation of symptoms, including 
tachycardia, hypertension, diaphoresis, hyperthermia and spontaneous 
posturing. These paroxysms occur at intervals throughout the day, usually in 
response to a stimulus or “trigger”. Once a stimuli manifests, the patient with 
PSH exhibits the multiple symptoms of physiologic distress. During these 
episodes, additional nursing care may be hampered in an effort to avoid 






PSH has been reported in up to 33% of patients with severe TBI (Hinson 
& Sheth, 2012) and is thought to increase morbidity and mortality related to TBI 
(Fernandez-Ortega et al., 2006). To date, the vast majority of literature pertaining 
to PSH is found in the medical literature with attention paid to hypothesis of 
cause and pharmacologic management. However, little is stated regarding the 
role of the nurse in the recognition and management of PSH. Clarification of this 
concept will aid the nurse in identifying the phenomena and guide interventions 
to improve the symptomatology and thereby outcomes.	
Rogers (2000) evolutionary method of concept analysis was used to 
evaluate the concept of PSH. This eight-step process allows for in depth 
investigation of the term, with interval development of model cases used to 
describe the phenomena of PSH, formerly known as sympathetic storming. The 
concept of PSH can also be considered in the theoretical context: the theory of 
unpleasant symptoms (Lenz, Pugh, Milligan, Gift, & Suppe, 1997; Lenz, Suppe, 
Gift, Pugh, & Milligan, 1995). This nursing theory was initially used to discuss the 
multiple symptoms (fatigue and dyspnea) in post-partum and COPD patients 
(Lenz et al., 1995). More recently, it has been used to investigate multiple 
symptoms in Alzheimer’s disease (Hutchinson & Wilson, 1998) and multiple 
sclerosis (Motl, 2014). In short, this middle range theory can be used to 
investigate the inter-relationships of multiple related symptoms as they exist in a 
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single disease process, and subsequently their effect on functional and cognitive 
performance (Lenz, Gift, Pugh & Milligan, 2012).	
Surrogate Terms	
PSH has been discussed in the literature under a variety of terms. Early in 
the recognition of this phenomenon, the term diencephalic seizure was used. 
However, later investigations failed to demonstrate seizure activity on 
electroenecephalography so this term became obsolete (Boeve et al., 1998a; 
Lemke, 2007). It later became known as dysautonomia, autonomic storming, 
sympathetic storming, and autonomic dysreflexia or hyper-reflexia. The 
International Brain Injury Association recently convened a consensus workgroup 
to clarify the nomenclature and diagnostic criteria for this entity. The proposed 
term is paroxysmal sympathetic hyperactivity (Baguley, 2013) although the term 
sympathetic storming maintains a clinical stronghold. 	
Methods	
A literature review was conducted using MEDLINE and CINAHL. No time 
limitations were specified. A search for the widely used clinical term of 
sympathetic storming combined with severe traumatic brain injury was 
performed. This search yielded only four articles. These articles and their 
corresponding reference lists were reviewed and additional search terms of 
diencephalic seizures, dysautonomia, autonomic storming, autonomic 
hyporeflexia, paroxysmal sympathetic hyperactivity, and autonomic hyper-reflexia 
were identified. These terms were also combined with traumatic brain injury to 
eliminate other similar autonomic conditions associated with congenital birth 
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defects, spinal cord injury, and other non-traumatic brain pathology. PSH and its 
surrogates were also combined with the term unpleasant symptoms, yielding no 
further results. The website for the Brain Injury Association of America was also 
queried as they were known to have a workgroup focusing on autonomic 
dysfunction. Additional query of the World Wide Web failed to produce any 
articles of sufficient quality to warrant inclusion. In sum, twenty articles specific to 
the concept of PSH were included. 	
References, Antecedents, and Consequences	
PSH, frequently called sympathetic storming, can be likened in some ways 
to the more well-known phenomenon, a thunderstorm. The thunderstorm occurs 
when in the presence of sufficient atmospheric moisture; warm air and cooler air 
collide, thus creating an unstable environment. Subsequently, the “symptoms,” 
thunder, lightning, wind gusts, and rain occur. In some cases, thunderstorms 
continue to move through a geographic area until the stimulus, usually water 
vapor has diminished (Anonymous, 2012). Like a thunderstorm, these 
sympathetic storms or paroxysms begin rapidly with minimal stimuli, yielding 
multiple symptoms while disrupting normal homeostasis of the body. Once the 
trigger is removed or afferent input blunted, the “storm” can then dissipate. 	
Acquired brain injury, specifically severe traumatic brain injury (TBI), is an 
absolute antecedent for the development of PSH. The presence of diffuse axonal 
injury on imaging studies has previously been associated with PSH (Baguley et 
al., 2004; Boeve et al., 1998a). Initial symptoms of PSH are frequently blunted by 
the use of opiates and sedatives in the intensive care unit. As these medications, 
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are weaned, symptoms may be become prevalent. Baguley suggests that PSH is 
present if 5 or more of the following symptoms are present without other 
identifiable causes: hyperthermia, tachycardia, tachypnea, dystonia, 
hypertension, posturing and diaphoresis (Baguley et al., 2014). No further 
attributes were identified). 	
If the symptoms are unrecognized or misattributed to other conditions by 
the nurse or medical team, a delay in appropriate treatment may result. A lag in 
condition specific treatment for these storming episodes can result in dysfunction 
of multiple organ systems. These consequences can result in permanent organ 
injury (i.e. myocardial infarction), prolonged intensive care unit length of stay, 
increased health care costs, and delayed recovery (Hinson & Sheth, 2012).	
Model Cases 	
Model Case	
SM is a 24-year-old male who was involved in a motor vehicle collision. 
He sustained a severe traumatic brain injury with an initial Glasgow Coma Score 
of 5. He required mechanical ventilation and intracranial pressure management 
for 10 days following his injury. Since weaning from the ventilator and sedation, 
he has developed periods of labile vital signs and other evidence of autonomic 
dysfunction. During these episodes, his heart rate (HR) is 150 beats per minute, 
blood pressure (BP) 170/92 mmHg, respiratory rate (RR) 38 breaths per minute, 
and he requires frequent linen changes due to profuse diaphoresis. At times, he 




TS is an 18 year old female who has been hospitalized for 24 hours 
following a penetrating brain injury. On admission, she had no corneal reflexes 
and fixed and dilated pupils. Her Glasgow Coma Score was 3. Most recent vital 
signs reveal HR 170 beats per minute, BP 200/98 mmHg, RR 12 breaths per 
minute per ventilator and intracranial pressure (ICP) 70 cm/H20. She has no 
motor response to noxious stimuli and no spontaneous respirations. While this 
patient is in a hyperadrenergic state, this scenario is more consistent with 
cerebral herniation syndrome than paroxysmal sympathetic hyperactivity.	
Interdisciplinary and Temporal Comparisons	
Nursing surveillance (Kelly, 2011) is conducted throughout the critical 
phases of TBI recovery. It is through this surveillance, observing abnormal vital 
signs and physical findings and interpretation of their meaning that the diagnosis 
of PSH is suspected. Communication of these findings to the medical staff is 
pivotal in confirming PSH as many of the symptoms (i.e. posturing, diaphoresis) 
are not readily ascertained from scanning the nursing notes or vital signs in the 
medical record. Even if identified, it is difficult to reconstruct the PSH or 
“storming” episode. Furthermore, the direct communication between nurses and 
medical staff remain critical with the increasing number of patient handoffs due to 
work hour restrictions, and transfer of care from specialists in neurological care to 
general practitioners who are less familiar with the complications associated with 
TBI. Another method of relaying the variability in the patient condition involves 
interdisciplinary team rounds. This method of communication has been shown to 
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improve outcomes in high-risk populations (Kauh, Polak, Hazelett, Hua, & Allen, 
2005).	
Implications	
Early identification and treatment of PSH is critical to facilitate recovery 
from traumatic brain injury and avoid permanent organ dysfunction. Expensive 
diagnostic testing is rarely warranted. Instead, the observational and analytical 
skills employed by most ICU nurses are most useful. In addition to 
communication of findings in order to facilitate diagnosis and treatment, nursing 
surveillance also affords the opportunity to identify and therefore, potentially 
mitigate triggers (Figure 2). These triggers or activities that may stimulate the 
sympathetic activity vary by patient and may be divided into external and internal 
stimuli. External triggers are commonly thought to be necessary nursing activities 
such as suctioning or positioning, caressing by the family, or excessive auditory 
stimulation (i.e. radio, monitor alarms) (Lemke, 2003; 2007). However, even with 
astute observation, a trigger is not always immediately identified and internal 
stimuli such as pain, constipation, or obstructed urinary catheters should be 
considered. A final contribution of nursing involves family and caregiver teaching. 
In this role, the nurse explains the concept of sympathetic storming or PSH, its 
causes, and treatment, thereby aiding the family member to better cope with the 
paroxysms (or “storms”) that can be very frightening or chaotic to watch. 	
Early initiation of symptom specific therapy, although beyond the scope of 
this paper, is thought to decrease complication rates, ICU length of stay, and 
facilitate recovery (Hinson & Sheth, 2012). Understanding both the cause and 
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complexity of these PSH events, will lead to improved diagnosis and therapeutic 
interventions. 	
Conclusion	
PSH should be considered when patients emerging from coma exhibit 
multiple, concurrent symptoms of sympathetic over-activity: hyperthermia, 
posturing, dystonia, tachycardia, tachypnea, diaphoresis, or hypertension. 
Nurses play a pivotal role in identifying the condition of PSH, observing and 
mitigating the triggers which precipitate the event, communicating patient needs 
to the interdisciplinary team, and finally, educating the family/caregivers. Ongoing 
research should include efforts to develop scales to document the frequency and 
severity of these paroxysmal episodes, as well as determine the impact of 
aggressive nursing care on the outcomes of this phenomenon.
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CHAPTER IV 
THE IMPACT OF PAROXYSMAL SYMPATHETIC HYPERACTIVITY 
FOLLOWING TRAUMATIC BRAIN INJURY ON INTENSIVE CARE UNIT 
LENGTHOF STAY AND DISCHARGE DISPOSITION		
Overview 
The purpose of this study was to determine the incidence of Paroxysmal 
Sympathetic Hyperactivity (PSH) in an American level 1 trauma center, and 
examined the differences between patients with severe TBI and those who 
develop PSH in terms of intensive care unit length of stay (ICULOS) and 
discharge disposition. Additionally, the study identified predictors of ICULOS in 
the patients with PSH.  
PSH is a complication affecting a subset of patients with severe traumatic 
brain injury. It is associated with increased morbidity, longer lengths of stay, and 
delayed recovery (Perkes, Baguley, Nott, & Menon, 2010). The most prevalent 
signs and symptoms of PSH include unprovoked tachycardia, tachypnea, 
hypertension, dystonia, and diaphoresis (Lemke, 2007). There has also been an 
association with prolonged pyrexia (Rabenstein, 2007). If untreated, PSH can 
lead to impaired cerebral perfusion, myocardial damage, dehydration, 
malnourishment, and contractures (Lemke, 2007).
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Background	
Traumatic brain injury (TBI) is a public health crisis with over 1 million new 
cases in the United States annually (Corrigan, Selassie, & Orman, 2010; CDC, 
2010). Approximately ten percent of these injuries result in severe TBI with 
prolonged periods of coma and post-traumatic amnesia (Bruns & Hauser, 2003). 
The impaired neurologic function associated with severe TBI requires prolonged 
hospitalizations, invasive monitoring and intensive neuro-rehabilitation and in 
many cases, can result in life-long disability. As a result, the small percentage of 
patients with severe TBI, utilize the biggest proportion of TBI resources and 
healthcare dollars (CDC, 2010; McIlvoy, 2001). An even smaller subset of severe 
TBI can develop paroxysmal sympathetic hyperactivity (PSH) (Baguley, 2008a; 
Baguley et al., 2009; Hinson & Sheth, 2012). This condition is characterized by 
periods of excessive activation of the sympathetic nervous system, resulting in 
intermittent episodes of hypertension, tachycardia, tachypnea, diaphoresis, and 
abnormal motor responses (Fernandez-Ortega et al., 2012; Gao, Pollock, & 
Hinson, 2014; Hinson & Sheth, 2012; Lemke, 2003; 2007). Known to mostly 
affect younger patients and those with diffuse rather than localized brain injury, 
PSH symptoms can last for days to years (Baguley et al., 2006; Fernandez-
Ortega et al., 2012; Lv et al., 2011). 
Because patients with PSH exhibit periods of physiologic distress, it is 
postulated that they have longer stays in the intensive care unit (ICULOS) and 
are more likely than other TBI patients to require ongoing medical care and 
increased resource utilization. A retrospective study was performed to determine 
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the differences in ICULOS and discharge dispositions from acute care. The 
physiologic parameters of heart rate (HR), systolic blood pressure (SBP), 
temperature (T), respiratory rate (RR), and free water requirements at specific 
time points during the hospital stay were explored to determine which factor most 
influenced ICULOS. 	
Methods	
A retrospective design of medical record review was used. A multivariate 
analysis of variance (MANOVA) was performed to determine group differences in 
the following parameters: heart rate (HR), systolic blood pressure (SBP), 
temperature (T), respiratory rate (RR), intracranial pressure (ICP) and free water 
requirements. In addition to age and GCS, physiologic factors showing statistical 
significance between groups were entered as predictors in a multiple regression 
model to determine factors most predictive of ICULOS, thereby facilitating a 
clinically relevant starting point for treatment of PSH. 
Measures 
Variables associated with PSH were identified from previous literature. 
Physiologic parameters were abstracted from the vital sign flow sheet record in 
the electronic medical record. The highest and lowest recorded values in a 24 
hour period where captured for each parameter. The first variable, HR was 
measured in beats per minute as auto-recorded by Hewlett-Packard telemetry. 
SBP, measured in mm Hg was captured preferentially from arterial line 
monitoring, In the absence of invasive SBP monitoring, values were captured 
from automatic non-invasive blood pressure cuff monitoring using Hewlett-
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Packard monitoring devices. Temperature, measured in degrees Fahrenheit was 
captured from the vital sign registry. Location of temperature measurement was 
not routinely identified. When a ventriculostomy was in place, ICP values in cm of 
water were obtained using strain-gauge catheters with Hewlett Packard 
monitoring. When measured by a parenchymal bolt, ICP was obtained from 
Integra® Camino® technology. Free water requirements were measured as the 
amount of water in milliliters required in a 24 -hour period to maintain normal 
serum sodium, blood urea nitrogen, and serum creatinine values. This 
information was abstracted from the medication administration record.  
Length of stay was calculated in days. ICULOS was calculated by 
subtracting the day transferred out of ICU from the day of admission. Hospital 
LOS was calculated by subtracting the day of discharge from the day of 
admission. Discharge disposition, i.e. the level of care the patient was 
transferring to following acute hospitalization, was identified from the nursing 
narrative and care coordination notes. The GCS was identified from the 
neurosurgery consultation and nursing notes. The Injury Severity Score (ISS) 
incorporates injury to different body parts to a summed score representing the 
overall injury severity. Higher ISS scores are associated with higher morbidity 
and mortality. The Abbreviated Injury Score- head (AIS-head) was captured as it 
reflects the injury severity specific to the head. The ISS ranges from 0-75 and 
AIS- head from 1-6; higher scores on both scales are indicative of more severe 
injury. The ISS and AIS-head were calculated at hospital discharge by the 
trauma registrars and were obtained directly from the Trauma Institute database. 
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Procedures 
Following approval of the local institutional review board (IRB), the trauma 
database was queried. A list (N= 620) was generated that included all trauma 
patients treated at a level 1 trauma center from the years 2010- 2015 presenting 
with evidence of a head injury and admission Glasgow Coma Score ≤ 8, 
indicating coma or severe TBI. The principal investigator reviewed each chart for 
inclusion/exclusion criteria. This yielded 196 cases meeting the inclusion criteria: 
severe TBI as defined by Glasgow Coma Score (GCS 4-8) and age greater than 
or equal to 16 at time of hospital admission. Cases were excluded if the post-
resuscitation GCS was 3 or > 8, there was concomitant spinal cord injury, 
presence of bilateral non-reactive pupils, orders for comfort measures only within 
the first 5 days of hospitalization, or there was the absence of a mechanical 
traumatic mechanism. A large number of cases were excluded as the admission 
GCS was influenced by the use of neuromuscular blocking agents or high dose 
sedatives (Table 2). Included cases were dichotomized into two groups by the 
principal investigator: those with documented PSH or strong suspicion based on 
chart review (PSH group, n = 45) and those without evidence of PSH (TBI group, 
n = 151). Data were extracted from the medical records on patient hospital days 





Analysis was performed using SPSS v 22. Student’s t-test was used to 
assess normally distributed data for differences in age, admission/discharge 
GCS, and overall ISS. Similarly, ANOVA was used to evaluate for differences in 
mechanism of injury and AIS-H and discharge disposition. Given appropriate 
correlations of the physiologic parameters, a MANOVA was used to assess for 
any between group differences. Statistically significant parameters were included 
in the multiple regression analysis using hierarchal entry to identify which factors 
were most likely to predict ICULOS. Not all patients required hospitalization 
through day 20. Therefore, every patient underwent analysis of physiologic 
parameters at days one and seven, but those with early discharges were 
removed from further analysis after their discharge date to avoid the appearance 
of excessive missing data.  
Results 
Admission Characteristics 
There was no difference in admission GCS between groups (TBI versus 
PSH); the mean of both groups was 6 (p=0.143). Age at time of injury was 
significantly different (p =.002) between groups (Table 3). Patients exhibiting 
PSH were younger (mean age 28 years, SD 10.7) compared to the TBI group 
(mean age 38 years, SD 15.9). Patients with PSH had significantly worse overall 
ISS (mean 32.9, SD 8.63) compared to the TBI group (mean 29.2, SD 10, p= 
0.012) although the severity of injury specific to the head was no different (AIS-h 
p=0.114). High velocity injury from motor vehicle collision was the predominant 
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mechanism of injury in both groups (TBI- 64% versus PSH 82%, p = 0.079) 
(Figure 3). 	
Patient Characteristics During Hospital Stay	
Day 7 analyses included all 196 patients. Patients were dichotomized to 
the TBI group (n = 151) and PSH group (n= 45) based on the presence or 
absence of PSH symptoms. Subject attrition due to early discharge resulted in 
181 patients included in the day 14 analyses, and 137 patients in the day 20 
analyses.  
Monitoring of intracranial pressure (ICP) was done at the discretion of the 
attending neurosurgeon. As a result, 81 patients had ICP monitoring on day 1, 
with 87 patients monitored on day 7 and only 33 patients required ongoing 
monitoring on day 14. Of those with ICP availability, there was a minor clinical, 
but statistically significant difference in mean ICPs between groups on day 1 but 
not on subsequent days (p=.001 with TBI mean 16.11 cm H20, SD 7.82 and PSH 
mean 22.83, SD 7.99).  
The amount of free water (mL) administered in order to maintain a normal 
sodium level was recorded as a marker of hydration status. This was found to 
only be significant on the day of discharge. Patients with PSH required a mean of 
829 mL (SD 789mL) while patients without PSH required only 366 mL (SD 479 
mL). Many of the patients in the standard TBI group (n=72), required no 
supplemental free water at hospital discharge.  
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Prior to analysis, statistical assumptions were assessed. Independence 
was confirmed as patients were assigned to only one group (TBI or PSH). 
Levene’s tests were non-significant indicating similar variances between groups. 
Evaluations of mechanism of injury and discharge dispositions initially failed to 
show a normal distribution, therefore, groups were collapsed to improve 
normality.  
Pearson correlation coefficients (r) indicated small to moderate 
correlations between the physiologic factors with absolute values of r ranging 
from .05 to .521. Additional testing for multicollinearity demonstrated a variance 
inflation factor (VIF) < 2 and tolerance > .3 for all parameters. Subsequently, a 
between subjects multivariate analysis of variance (MANOVA) was conducted to 
evaluate the physiologic parameters of heart rate (HR), systolic blood pressure 
(SBP), respiratory rate (RR), and temperature (T) in patients with and without 
PSH. Parameters included were the daily minimum value, daily maximum value, 
and frequency that the parameter was recorded outside of the pre-established 
normative range during the 24-hour collection period. Day one data was initially 
collected but not analyzed for two reasons. First, the literature clearly states that 
PSH is not present at the time of injury (day 1), and secondly, the protocol did not 
include a mechanism to control for the physiologic abnormalities associated with 
resuscitation and in some cases, hypovolemic shock. The results from days 7, 
14, and 20 are presented in Tables 4, 5, and 6 respectively. Day 7 reflected 
between group differences in maximal HR (p< .001), HR frequency (p = .004) 
and maximal RR (p= .008). Post hoc testing demonstrated marginal effect sizes 
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with Odds Ratio (OR) of 1 and confidence intervals (CI) centered at 1 for all three 
parameters, suggesting that all though there was statistical significance between 
groups the difference had no bearing on the overall outcomes of LOS or 
discharge disposition. Day 14 analysis yielded only significant findings of 
maximal HR (p <.001, OR 1.006, CI 1.022-1.010) and maximal RR (p = .038, OR 
1.027, CI 1.017 -1.038). By day 20, no significant differences in any parameters 
were noted between groups.  
The final aim of this research was to determine which previously identified 
factors significant predicted ICULOS. To address this aim, ICULOS was 
regressed on the factors HR maximum day 7, HR frequency day 7, HR maximum 
day 14, RR maximum day 7, and HR frequency on day of discharge, in a 
hierarchical fashion. Factors were entered into the regression equation based on 
the degree of statistical significance from the previous MANOVA. ISS and age 
were also significant on initial analysis and were subsequently added to the final 
models. Maximum HR day 7 was entered in the first block, yielding an 
insignificant result. Maximum HR day 14 was added next, explaining 5.6% of the 
variability in ICULOS (R2 = .056, F1,174 = 10.247, p = 0.002). HR frequency at day 
7 was then added without noticeable contribution. Maximum RR at day 7 was 
then added producing R2 =.124 with R2 change of .068 (F1, 172 = 13.366, p < 
.001). HR frequency at discharge, RR minimum at discharge, age, and ISS were 
subsequently added in additional blocks without appreciable explanation of 
variability or statistical significance. Although model 4, which incorporated HR 
maximum for days 7 and 14, HR frequency at day 7 and RR maximum at day 7 
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accounted for only 12.4% of the variability in ICULOS, it was believed to be most 
reliable predictor of ICULOS.  
Discharge Characteristics 	
All patients had day of discharge comparisons although the length of stay 
varied considerably (range 14-143 days). Both ICU and hospital lengths of stay 
were similar between groups (p= .245 and p= .1 respectively). Median ICULOS 
was 18.1 days (SD 10.6 days) in the TBI group and 19.1 days (SD 9.84 days) for 
the PSH group while hospital length of stay (HOSPLOS) was 28.4 days (SD 19.3 
days) in the TBI group and 30.2 days (SD 15 days) in the PSH group (Table 7). 
Discharge GCS was significantly lower in the PSH group (p=.002). Mean 
GCS in the PSH group was 10.8 (SD 2.55) compared to the TBI group mean of 
12.1 (SD 2.93). 
When evaluating discharge dispositions, an ANOVA was used with the 
following discharge disposition groups:  1. Home or assisted living	2. Acute rehabilitation 	3. Sub-acute rehabilitation, coma emergence programs or skilled 
nursing facility	4. Other or not specified disposition (includes long-term acute care, 
other acute care hospitals). 	
The F test was statistically significant (p= .009) suggesting that patients with PSH 
were less likely to be discharged to home (2.2%) compared 8.6 % in the TBI 
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group, or acute rehabilitation settings (42.2% PSH group versus 69.9% TBI 
group). 
Post hoc testing showed a small to moderate effect between the groups 
with home versus acute rehabilitation (Odds Ratio (OR) 1.473 and 95% 
confidence interval (CI) 0.155-13.99), sub-acute rehabilitation versus acute 
rehabilitation (OR 0.112, 95% CI 0.036-0.353) and other versus acute 
rehabilitation (OR 0.160, 95% CI 0.022-1.143). Essentially, patients with an 
expected TBI course were 1.5 times more likely to be discharged to high level 
neuro-rehabilitation than those with PSH and were substantially less likely to 
require long-term skilled nursing or sub-acute rehabilitation.	
Discussion	
Findings from this study and others, suggest that despite appropriate TBI 
treatment, up to one third of the severe TBI population will develop PSH; a 
complication that increases hospital length of stay, morbidity, and long-term 
disability (Hendricks, Heeren, & Vos, 2010; Hinson & Sheth, 2012; Lv et al., 
2010; & Perkes et al., 2010). Data from this study suggests that multiple 
episodes of tachycardia, present on post-injury days 7 and 14, are associated 
with the development of PSH. Other factors, including temperature, blood 
pressure, and respiratory rate appear to be less indicative of PSH. 
Upon discharge from acute care, disposition varies mostly based on the 
patients level of arousal, although social factors or health system factors may 
also influence discharge disposition. For example, Argentina lacks formal neuro-
rehabilitation programs; therefore, over 60% of patients with TBI are discharged 
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to homecare (Rondina et al., 2005). Acute rehabilitation typically requires that 
patients actively participate in three or more hours of therapy a day and is the 
preferred discharge locale for patients with significant TBI. In the Unites States, 
over fifty percent of patients with severe TBI are discharged to rehabilitation 
(Bauer, McGwin, Melton, George, & Markert, 2011; Livingston, Tripp, Biggs, & 
Lavery, 2009). Transfer to sub-acute rehabilitation or skilled nursing facilities is 
largely associated with lower Glasgow Coma Score or other socioeconomic 
factors, specifically, government funded healthcare (Chan et al., 2001; Cuthbert 
et al., 2011; Hoffman et al., 2012). Bauer et al., (2011) reported that 25% of his 
sample were discharged to sub-acute rehabilitation with only 13% discharged to 
home. Others report rehabilitation rates as high as 89%, although there was no 
distinction between acute and sub-acute rehabilitation (McIlvoy, 2001; Vitaz et 
al., 2001). A cost benefit analysis suggests that aggressive care of the TBI 
patient, including acute rehabilitation is “significantly less costly than routine care” 
over time (Whitmore et al., 2012). 
While this study indicates that PSH has no effect on short-term outcomes, 
such as ICULOS or HOSPLOS, the findings suggest that patients with PSH are 
less likely to qualify for acute rehabilitation upon hospital discharge. Because 
patients with PSH are discharged with lower levels of neurologic function, it can 
be inferred that patients with PSH have prolonged resource needs at increased 
costs and are less likely to receive specialty neurotrauma rehabilitation, which 
may further delay recovery and community re-entry. It remains unclear what 
factors are related to delayed responsiveness (lower GCS) in patients with PSH 
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and if any treatment modalities to improve early wakefulness (higher GCS) might 
lead to earlier brain injury rehabilitation.  
Contrary to expected findings, there were minimal differences in virtually 
all physiologic parameters. While this may be related to early treatment of PSH, it 
may also be affected by the small sample size. Given the hemodynamic 
similarities between groups, it is not surprising that that no difference in ICULOS 
was identified. Except for free water requirements, no other differences in 
physiologic parameters were identified on the day of discharge. It was anticipated 
that parameters on day of discharge would be non-significant as a labile 
hemodynamic status is a contraindication for discharge.	
Limitations  
This study has several limitations. The sampling bias associated with use 
of a convenience sample limits the generalizability of these findings to other 
populations. Future studies would benefit from multi-center sampling.  
The retrospective nature of the study limited the usefulness of the recently 
standardized definition of PSH that requires patients to exhibit five or more of the 
following symptoms without provocation: hyperthermia, dystonia, tachypnea, 
diaphoresis, hypertension, and tachycardia. Patients were included in the PSH 
group if they carried a diagnosis of PSH or had only 3 or more associated 
symptoms occurring 3 or more times in a 24 hour period since it was not possible 
to readily identify symptoms such as dystonia or diaphoresis from the existing 
documentation. Therefore, patients may have been included in the PSH group 
without meeting all diagnostic criteria. 	
33		
Retrospective studies are traditionally at high risk for missing data. In an 
effort to mitigate this, variables were collected across a 24-hour period instead of 
specified hours, thus ensuring capture of minimum and maximum values for each 
physiologic parameter. Facility policy dictates hourly vital signs with the exception 
of temperatures (monitored every 4 hours) in acute trauma patients; as a result, 
temperatures were the only variable with missing data. This condition was 
isolated to patients who were admitted after 8 pm. 	
The scope of this study did not allow for evaluation of treatment effects on 
PSH. While it appears that patients with PSH exhibit slower awakening than their 
counterparts as evidenced by the lower discharge GCS, it is not clear if this is 
related directly to the development of PSH or other dynamic elements. Other 
factors that may contribute to ongoing poor neurologic function include cortical 
and subcortical pathologies, delayed initiation of neuro-stimulants because of 
adrenergic hyperactivity, hormonal imbalances or other unidentified conditions. 	
Finally, during the years of interest, the principal investigator was actively 
engaged in the critical care management of patients with severe TBI and 
pursuing research interests in PSH. As a result, patients with PSH were 
diagnosed within the first two weeks of injury and symptoms were treated 
accordingly. The lack of statistical significance between groups may be a 




Despite the study’s limitations, findings indicate it is reasonable to utilize 
routine screening mechanisms for PSH in high-risk patients with severe TBI, 
particularly younger patients with early evidence of unprovoked tachycardia. 
Lower discharge GCS and discharge to facilities other than acute rehabilitation, 
suggest that patients with PSH have a delayed recovery. Additional studies are 
needed to determine if coma stimulation-type interventions improve the 
wakefulness of patients with PSH, therefore allowing earlier attempts at neuro-
rehabilitation. Additional studies evaluating the efficacy of different treatment 
modalities are necessary in order to establish an evidence-based treatment 
algorithm for PSH. Lastly, future projects should focus on determining if 
differences in long-term recovery and functional status exist or if the natural 




Explanation of Included and Excluded TBI Cases		
Total Cases With Admit 




    N = 620	
Excluded	 	
Death	 N=424	N=113	
	 Mild TBI (GCS 13-15)	               N=69	
	 Moderate TBI (GCS 9-
12)	                   N=203	
	 No TBI (anoxia, stroke)	               N=39	
	 Age<16	               N=2	
	 Transfer within 1 week	               N=1	
Included	 Post-resuscitation GCS 
4-8	 N=196		
GCS- Glasgow Coma Score 
TBI- Traumatic brain injury
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Table 3	
Admission Characteristics of Patients with Severe Traumatic Brain Injury 
Admitted to a Level 1 Trauma Center Between 2010-2015 (N=196).	



























 GCS= Glasgow Coma Score	
ISS= Injury Severity Score	




Hospital Characteristics of Patients with Severe TBI on Day 7 (N=196) 
Variable TBI Group 
(N=151) 
PSH Group  
(N= 45) 
Significance 
HR beats per min 
   Min Mean (SD) 
   Max Mean (SD) 
   Frequency (SD) 
 
  74.1 (14.8) 
107 (17.6) 






        p= 0.774 
  p=<0.001* 
 p= 0.003* 
SBP mm Hg 
   Min (SD) 
   Max (SD) 










        p=0.148 
p= 0.797 
p= 0.807 
Temp degrees F 
   Min (SD) 
   Max (SD) 
   Frequency (SD) 
 
 98.7 (0.97) 
       101 (1.2) 










   Min (SD) 
   Max (SD) 














TBI- Traumatic brain injury 
PSH- Paroxysmal sympathetic hyperactivity 
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HR- Heart rate in beats per minute 
SBP- Systolic blood pressure 
Temp- Temperature in degrees Fahrenheit 
RR- Respiratory rate in breaths per minute 
SD- standard deviation 
Min-Minimum value 
Max-Maximum value 
Frequency- Number of times above pre-defined normal value 
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Table 5 
Characteristics of Patients with Severe Traumatic brain Injury on Hospital Day 14 
(N= 181) 





HR-beats per min 
   Min (SD) 
   Max (SD) 













SBP mm HG 
   Min (SD) 
   Max (SD) 













Temp in F 
   Min (SD) 
   Max (SD) 














   Min (SD) 
   Max (SD) 













Free Water (mL)    








SD- Standard deviation 
TBI- Traumatic brain injury 
PSH- Paroxysmal sympathetic hyperactivity 
Temp- Temperature 
Min- Minimum value 
Max- Maximum value 
Frequency- Number of times above predefined normal value 
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Table 6 
Characteristics of Patients with Severe Traumatic Brain Injury on Hospital Day 20 
(N= 137) 





HR beats /min 
   Min (SD) 
   Max (SD) 













SBP mm Hg 
   Min (SD) 
   Max (SD) 













Temp deg F 
   Min (SD) 
   Max (SD) 














    Min (SD) 
    Max (SD) 













Free Water (mL)  296 (463) 391 (573) p=0.434 
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TBI- Traumatic brain injury 
PSH- Paroxysmal sympathetic hyperactivity 
HR beat/min- Heart rate in beats per minute 
SBP- Systolic blood pressure 
Temp deg F- Temperature in degrees Fahrenheit 
RR- Respiratory rate in breaths per minute 
SD- Standard deviation 
Frequency- Number of times above predetermined normal value 
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Table 7	
Discharge Characteristics of Patients with Expected TBI Recovery and Those 
with PSH (N= 196).	
Variable TBI (n= 151)	 PSH (n= 45)	 Significance	
Discharge GCS	
   Mean(SD)	










   Mean (SD) day	
   Median day	












   Mean (SD) day	










   Acute %	
   Home/AL %	
   SAR/SNF/Emerge %	














TBI- Traumatic brain injury 
PSH- Paroxysmal sympathetic hyperactivity 
GCS- Glasgow Coma Score	
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ICULOS- Intensive Care Unit length of stay	
HOSPLOS- Hospital Length of Stay	




SNF- Skilled nursing facility	
Emerge- Coma emergence program
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Figure 3	
Mechanism of injury for traumatic brain injury, years 2010-2015TBI versus PSH 
groups (p=.079)	
		
MVC includes: All-terrain vehicle, motorcycle, motor vehicle, and moped crashes		
Ped v Auto- includes any pedestrian struck my motorized vehicle		









Paroxysmal sympathetic hyperactivity is a complication that follows TBI in 
a small percent of patients in a coma (Fernandez-Ortega et al., 2012). Although 
cases of PSH were identified over 60 years ago, formal diagnostic criteria and 
nomenclature have only been established within the last five years (Baguley et 
al., 2014). To date, most of the research in this area has emerged from a single 
group in Australia. Their findings indicate that patients who develop PSH are at 
risk for increased morbidity, prolonged ICULOS, and delayed recovery 
(Fernandez-Ortega et al., 2012; Baguley, 2008a; Penfield, 1929; Baguley et al., 
2006; Baguley et al., 1999). 
Consistent with prior research, this study suggests that younger patients 
with severe TBI are most at risk for developing PSH. The presence of diffuse 
axonal injury on imaging studies has been associated with PSH (Hinson & Sheth, 
2012; Lv et al., 2011). However, other clinically relevant injury related factors 
(AIS-head, ICP, admission GCS) do not have an obvious linkage to the 
development of PSH. 
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 Early and persistent episodes of non-specific tachycardia appear to be 
the most sensitive indicator for PSH although other factors such as early 
tachypnea and late pyrexia after TBI may also indicate the presence of PSH. As 
most of the patients in this study were diagnosed with PSH early in their hospital 
course and had ICULOS similar to their TBI counterparts, it is possible that early  
PSH intervention may prevent prolonged ICULOS and thereby associated 
complications. Comparative studies looking the effects of early versus delayed 
treatment of PSH may offer insight into the differences in outcomes from various 
studies.  
Despite similar admission characteristics, ICULOS, and HOSPLOS, 
patients with PSH appear to have slower awakening from coma as evidenced by 
lower discharge GCS. Poor neurologic function at discharge likely influences 
discharge disposition. Patients with PSH are less likely to be discharged to acute 
neurorehabilitation than their TBI counterparts who follow an expected TBI 
recovery trajectory.  
 Much is left to learn about the complex condition of PSH. Future research 
priorities should include:  
• Creation and validation of a PSH screening tool 
• Development of evidence-based treatment protocols 
• Establishment of the natural history of PSH  
• Determine the long-term functional outcomes of patients with PSH 
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Due to the low incidence of PSH, sample size limitations pose a significant 
problem in powering single site studies. For this reason, multi-center studies 
should be considered.  
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